All lobbying filings
S-3 GROUP
Lobbying for AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. · Biopharmaceutical development
Filing
1st Quarter - Report
Reporting period
1st Quarter 2026
Jan 1 - Mar 31 · Posted Apr 17, 2026
Income
$60,000.00
What the client paid this registrant for the period.
Client based in
Illinois
Lobbyists on this filing
7
-
MICHAELEEN EARLE CROWELLPreviously held: Leg Director, Rep. Denise Majette; Leg Director, Rep. John Lewis; Chief of Staff, US Sen. Bernie Sanders
-
KEVIN CASEYPreviously held: Senior Pol Dir, Dem Caucus; Counselor, Leg. Dir, Leg. Asst, Rep. Joseph Crowley; Staff Asst, Leg. Correspondent, Rep. Bob Weygand
-
OLIVIA KURTZPreviously held: Chief of Staff, Leg Director, Dep Leg Director, Sr Leg Asst, US Sen Susan Collins; Dep Staff Dir, Sen Special Comm on Aging; Leg Director, Sr Leg Asst, Leg Asst, Exec Asst, Rep Mike Castle
-
MARTIN REISERPreviously held: Policy Director, Republican Whip Steve Scalise, professional staff House Ways and Means Committee, Chief of Staff, Rep. Dan Miller, Budget Associate, House Budget Committee
-
CHANDA BETOURNEYPreviously held: Dep. Staff Director and Chief Counsel, Senate Appropriations Cmt; Chief Counsel Civil Law and Oversight, Sen. Counsel, Sen. Judiciary Cmt; Leg Asst. and Projects Dir., Leg. Corresp., Senator Leahy
-
MARTIN DELGADO New on this filingPreviously held: Staff Dir, House Ag Approps, MilCon/VA Approps; Prof Staff, House Ag Approps, Senate Interior Approps; Budget Analysis, USDA APHIS
-
CHRIS ARNESON New on this filingPreviously held: Economic Policy Director, Chief Budget and Economic Advisor, Senior Tax Policy Advisor, Tax Policy Advisor, Research Associate, Research Assistant, Associate Investigator, Senate Finance Committee.
Government bodies contacted
2
Lobbying activity
2
H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019
Issues related to health care research